These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1196 related articles for article (PubMed ID: 15913452)
41. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture. Madne TH; Dockrell MEC Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706 [TBL] [Abstract][Full Text] [Related]
42. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Paul DS; Harmon AW; Devesa V; Thomas DJ; Stýblo M Environ Health Perspect; 2007 May; 115(5):734-42. PubMed ID: 17520061 [TBL] [Abstract][Full Text] [Related]
43. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Horwood JM; Dufour F; Laroche S; Davis S Eur J Neurosci; 2006 Jun; 23(12):3375-84. PubMed ID: 16820027 [TBL] [Abstract][Full Text] [Related]
44. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Alessi DR; Deak M; Casamayor A; Caudwell FB; Morrice N; Norman DG; Gaffney P; Reese CB; MacDougall CN; Harbison D; Ashworth A; Bownes M Curr Biol; 1997 Oct; 7(10):776-89. PubMed ID: 9368760 [TBL] [Abstract][Full Text] [Related]
45. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas. Nozhat Z; Hedayati M Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586 [TBL] [Abstract][Full Text] [Related]
46. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Chalhoub N; Zhu G; Zhu X; Baker SJ Genes Dev; 2009 Jul; 23(14):1619-24. PubMed ID: 19605683 [TBL] [Abstract][Full Text] [Related]
47. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells. Semba S; Itoh N; Ito M; Harada M; Yamakawa M Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641 [TBL] [Abstract][Full Text] [Related]
48. Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. She QB; Solit D; Basso A; Moasser MM Clin Cancer Res; 2003 Oct; 9(12):4340-6. PubMed ID: 14555504 [TBL] [Abstract][Full Text] [Related]
49. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat. Kim Y; Hollenbaugh JA; Kim DH; Kim B PLoS One; 2011; 6(7):e21781. PubMed ID: 21765914 [TBL] [Abstract][Full Text] [Related]
50. Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells. Wu Y; Zu K; Warren MA; Wallace PK; Ip C Mol Cancer Ther; 2006 Feb; 5(2):246-52. PubMed ID: 16505097 [TBL] [Abstract][Full Text] [Related]
51. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057 [TBL] [Abstract][Full Text] [Related]
52. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling. Chuenkova MV; Furnari FB; Cavenee WK; Pereira MA Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9936-41. PubMed ID: 11481434 [TBL] [Abstract][Full Text] [Related]
53. Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes. Wilhelm F; Kässner F; Schmid G; Kratzsch J; Laner A; Wabitsch M; Körner A; Kiess W; Garten A Growth Horm IGF Res; 2015 Jun; 25(3):115-20. PubMed ID: 25900365 [TBL] [Abstract][Full Text] [Related]
54. PI3K/AKT pathway activation in bladder carcinogenesis. Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582 [TBL] [Abstract][Full Text] [Related]
55. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810 [TBL] [Abstract][Full Text] [Related]
56. PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus. Zhu L; Zhao S; Liu S; Liu Q; Li F; Hao J J Cell Biochem; 2016 May; 117(5):1187-98. PubMed ID: 26447680 [TBL] [Abstract][Full Text] [Related]
57. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples. Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967 [TBL] [Abstract][Full Text] [Related]
58. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Gulati N; Laudet B; Zohrabian VM; Murali R; Jhanwar-Uniyal M Anticancer Res; 2006; 26(2A):1177-81. PubMed ID: 16619521 [TBL] [Abstract][Full Text] [Related]
59. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. Park JK; Jung HY; Park SH; Kang SY; Yi MR; Um HD; Hong SH Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1552-60. PubMed ID: 18374229 [TBL] [Abstract][Full Text] [Related]
60. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]